The Hugely Inflated Prices of Glumetza and Metformin ER

I may have been very late to the astonishing price increase of Glumetza, but I am, by coincidence, among the first to report that the generic price is almost as ridiculous. My bill, $14,009.23, was for the generic, available, as promised, in February 2016 and manufactured by Lupin, an Indian pharmaceutical company that is the sixth largest maker of generics in the world. Read more

Metformin and Type 1 Diabetes – An Experiment

Metformin is not usually prescribed for Type 1 diabetes, but over the past couple years, inspired in part by Mike’s experience on it (see here, here, here and here), I’ve become interested in trying it. Not only has it been … Read more

Why Isn’t Everyone Taking Metformin?

It seems like every week there’s a new reason to be happy to be taking metformin. Last week (or was it two weeks ago) a new study found evidence suggesting that taking metformin reduces the risk of developing dementia. Now, … Read more

Diabetes and Dementia: Is Metformin the New Aspirin?

Research suggests there is a close relationship between diabetes and dementia (and more specifically, diabetes and Alzheimer’s). I know I shouldn’t be worried about it since I’m well controlled and most of the data about diabetes and dementia refers to … Read more

Metformin Works Differently Than Previously Thought

New research from the University of Pennsylvania has discovered that the most popular type 2 diabetes medication, metformin, works differently than previously thought. Metformin was known to lower blood glucose levels by decreasing the amount of glucose produced by the liver, but how the drug did this was not known. Read more

Patient Power: I Discovered Metformin Myself

For the past few days I’ve been in a good mood. It seems as if I have finally found a way to deal with my biggest diabetes management issue – morning highs. And what makes it even better is that … Read more

Diabetes and Cancer: Can Metformin Treat Both?

The association between diabetes and cancer was first noted over 100 years ago, but physicians have become increasingly aware of this association only in the last few years as recent studies have demonstrated that having diabetes increases the risk of almost all types of cancer. The risk of pancreatic, liver, and endometrial cancer is approximately twice that of the non-diabetic population. Some studies have reported a similar increase in the risk of bladder cancer and in cancers of the oral cavity. Read more

Children with Type 2 Diabetes do Better with Avandia

The results of a randomized clinical trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in children with type 2 diabetes show that children and adolescents treated with a combination of metformin and Avandia (rosiglitazone) had better glycemic control than children…. Read more

Why I Chose Metformin

Prediabetes is like the two minute warning just before the end of the first half in a football game… Read more

Subscribe to our Newsletter

Hide me